Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27768104 | 1.00 | TSHR (0.44) | TSHRTDP1LMNAALDH1A1CA1 | |
| SCHEMBL671825 | 1.00 | TSHR (0.44) | TSHRTDP1LMNAALDH1A1CA1 | |
| Alcohol SCHEMBL26136441 | 0.95 | TSHR (0.40) | TSHRTDP1LMNAALDH1A1TRPA1 | |
| Acetic Acid SCHEMBL29257656 | 0.88 | SLC1A3 (0.35) | TSHRTDP1ALDH1A1CA1 | |
| SCHEMBL5479762 | 0.82 | TSHR (0.33) | TSHRLMNA | |
| SCHEMBL15027382 | 0.80 | TSHR (0.35) | TSHRALDH1A1TRPA1 | |
| SCHEMBL17417051 | 0.80 | TSHR (0.42) | TSHRTDP1LMNAALDH1A1TRPA1 | |
| SCHEMBL890533 | 0.79 | — | — | |
| SCHEMBL18124636 | 0.78 | TSHR (0.33) | TSHRTDP1LMNATRPA1 | |
| SCHEMBL18124662 | 0.78 | TSHR (0.33) | TSHRTDP1LMNATRPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4504681-A1 | METHOD FOR THE PREPARATION OF A VOLATILE MIXTURE OF ALKANES AND A COSMETIC COMPOSITION | Biosynthis (FR) | 2025-02-12 | — | — | EP | disclosed |
| EP-4496553-A1 | COSMETIC COMPOSITION APPLICABLE TO THE SKIN AND BASED ON A VOLATILE MIXTURE OF ALKANES | Biosynthis (FR) | 2025-01-29 | — | — | EP | disclosed |
| WO-2023187226-A1 | METHOD FOR THE PREPARATION OF A VOLATILE MIXTURE OF ALKANES AND A COSMETIC COMPOSITION | BIOSYNTHIS (FR) | 2023-10-05 | — | — | WO | disclosed |
| WO-2023166204-A1 | COSMETIC COMPOSITION APPLICABLE TO THE SKIN AND BASED ON A VOLATILE MIXTURE OF ALKANES | BIOSYNTHIS (FR) | 2023-09-07 | — | — | WO | disclosed |
| WO-2023166198-A1 | EYE MAKEUP COMPOSITION BASED ON A VOLATILE MIXTURE OF ALKANES | BIOSYNTHIS (FR) | 2023-09-07 | — | — | WO | disclosed |
| WO-2023166194-A1 | LIPSTICK COMPOSITION BASED ON A VOLATILE MIXTURE OF ALKANES | BIOSYNTHIS (FR) | 2023-09-07 | — | — | WO | disclosed |
| US-20170281627-A1 | TOLL LIKE RECEPTOR MODULATOR COMPOUNDS | GILEAD SCIENCES, INC. | 2017-10-05 | — | — | US | disclosed |
| US-9670205-B2 | Toll like receptor modulator compounds | GILEAD SCIENCES, INC. (US) | 2017-06-06 | — | — | US | disclosed |
| US-20170071944-A1 | MODULATORS OF TOLL-LIKE RECEPTORS FOR THE TREATMENT OF HIV | GILEAD SCIENCES, INC. | 2017-03-16 | — | — | US | disclosed |
| US-20160289229-A1 | TOLL LIKE RECEPTOR MODULATOR COMPOUNDS | GILEAD SCIENCES, INC. | 2016-10-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170281627-A1 | TOLL LIKE RECEPTOR MODULATOR COMPOUNDS | TLR8, TLR3, TLR6 | TSHR 1106/4885TDP1 1216/4885LMNA 3552/4885 |
| US-20160289229-A1 | TOLL LIKE RECEPTOR MODULATOR COMPOUNDS | TLR8, TLR3, TLR6 | TSHR 1106/4885TDP1 1216/4885LMNA 3552/4885 |
| US-20170071944-A1 | MODULATORS OF TOLL-LIKE RECEPTORS FOR THE TREATMENT OF HIV | TLR8, TLR3, TLR6 | TSHR 2756/4885TDP1 2809/4885LMNA 4121/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.